Navigation Links
Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Date:11/11/2010

BEDMINSTER, N.J., Nov. 11, 2010 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that Jerry Wisler, President and Chief Executive Officer, will present at the Lazard Capital Markets 7th Annual Healthcare Conference at the St. Regis hotel in New York City on November 17, 2010 at  1:15pm Eastern time.

About Omthera Pharmaceuticals, Inc.Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately-held, emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia.  Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.  The lead product candidate is Epanova, an Omega 3 fatty acid compound preparing to enter Phase III clinical development as a triglyceride-lowering adjunct therapy to diet in patients with very high triglycerides (greater than or equal to 500 mg/dL).  Future planned clinical trials for Epanova include patients with high triglycerides (greater than or equal to 200 mg/dL and less than or equal to 500 mg/dL) currently on statin therapy.  Omthera holds worldwide rights to Epanova.   For more information, please visit www.omthera.com.Media ContactRx Communications Group, LLCEric GoldmanVice President, Public Relations917-322-2563egoldman@rxir.com
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
7. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  LumiThera Inc., a medical device company focused on ... disorders and disease, today announced Retired Congressman Norman ... to assist in the company,s mission to treat vision ... the U.S. Representative for Washington,s ... is a member of the Democratic Party. His district ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4fgrnh/asiapacific ) ... Internal Trauma Fixation Devices Market by Type & ... report to their offering. The ... to grow at a CAGR of 6.7% from ... rising incidences of road accidents, increasing aging population, ...
(Date:5/6/2015)... 6, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the Bank of America Merrill Lynch 2015 Health Care Conference ... from the Encore at the Wynn in Las ... be accessed at www.meipharma.com . A replay will be ...
Breaking Medicine Technology:Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2
... 8, 2010 Hologic, Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and surgical products ... its results for the fourth fiscal quarter and fiscal year ... the quarter include: Revenues of $428.3 million. Fourth ...
... Nov. 8, 2010 PLC Systems Inc. (OTC Bulletin Board: ... device-based technologies, today announced that it had signed a definitive ... to Novadaq Technologies Inc. (TSX: NDQ), a developer ... Novadaq has been the exclusive United States distributor of PLC,s ...
Cached Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results 20PLC Systems Signs TMR Asset Sale Agreement with Novadaq 2PLC Systems Signs TMR Asset Sale Agreement with Novadaq 3
(Date:5/6/2015)... 06, 2015 Chesapeake Regional Medical ... of Virginia to acquire Intuitive Surgical, Inc.’s latest ... system upgrade includes enhanced surgical technique capabilities, which ... across a wide spectrum of specialties. Its advancements ... and quicker recovery times. , “As the only ...
(Date:5/6/2015)... Dallas, TX (PRWEB) May 06, 2015 ... 2, Issue 1 of Patient Experience Journal (PXJ), ... and proven practices around understanding and improving patient experience. ... elevating the patient experience conversation globally, helps align the ... and impact. , Published in association with The ...
(Date:5/6/2015)... Is Colorado’s legal cannabis industry the ... Centennial State will mark the 18-month milestone of its ... And while Colorado’s legal marijuana industry has been successful ... also facing some new challenges. , For example, many ... especially in the wake of last month’s “420” cannabis ...
(Date:5/6/2015)... May 06, 2015 vcfo, a specialized ... IT and operational support to optimize business performance and ... Jack Lynch and Michael Scheaffer. Both Lynch and Scheaffer ... leadership experience. , “We are delighted to add ... vcfo CEO. “Leveraging their background in financial management and ...
(Date:5/6/2015)... 2015 Anitoa Systems, (“Anitoa”), a Palo ... University of China, has successfully demonstrated a handheld real ... sensor. Anitoa’s handheld qPCR is shown to be ... RNA’s, including hepatitis B, C, and E. Coli. This ... per sample and over 9 orders of magnitude dynamic ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... N.J., Feb. 11 Tibotec Therapeutics, a division ... the availability of a lower-dose (75 mg) formulation ... The announcement follows the FDA approval of PREZISTA, ... agents, for the treatment of HIV infection in ...
... , , ... ... +3.7% EUR7,089m +3.6%, Adjusted net income, ... +3.2% EUR1,627m +13.9%, Adjusted EPS excluding EUR5.49 ...
... Blue Cross and Blue Shield of Florida (BCBSF) is ... Coalition (FLC) a three-year grant for the establishment of ... grant is to create a new emphasis on health ... adult ESOL (English for Speakers of Other Languages) and ...
... Triple-S Management Corporation (NYSE: GTS ) ... its financial results for the fourth quarter and year ... analysis of certain securities in the Company,s investment portfolio. ... results will be reported after the impairment analysis is ...
... the New Face of FrugalityNEW YORK, Feb. 11 ... Lewis, counsels private clients on all aspects of cosmetic ... lasers, skincare, tummy tucks, facelifts and more. When ... facelift in today,s tough economy, Lewis, who opened Wendy ...
... USC Now Available OnlineSAN FRANCISCO, Feb. 11 ... edition of the Journal of the American Geriatrics Society are ... improve memory and attention in older adults. An advance copy ... University of Southern California and the Mayo Clinic has ...
Cached Medicine News:Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 2Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 3Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 4Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 5Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 6Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 7Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 2Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 3Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 4Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 5Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 6Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 7Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 8Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 9Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 10Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 11Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 12Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 13Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 14Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 15Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 16Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 17Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 18Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 19Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 20Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 21Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 22Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 23Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 24Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 25Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 26Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 27Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 28Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 29Health News:Sanofi-aventis Delivers 2008 Results Above Guidance 30
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... transfer samples from 96-well plates ... Accurately deliver 0.5-5 μl. Complete ... six minutes or less. Compatible ... and other gels with microwell ...
... Equally Spaced, Expandable, Multichannel Pipettor ... pipettors and instantly boosts productivity with an ... the simple adjustment of a slide rod. ... transfer of liquids between vessels with different ...
Medicine Products: